Unlocking the Power of Statistics from Start to Finish
Statistics isn't just a tool for post-study analysis; it's a driving force that should be integrated into every step of the journey toward bringing a new drug or a medical device to market. From the very inception of a study to risk management, enrollment enhancement, and management, statistics plays a pivotal role
- Drug and CDx co-development
- Bridging studies
- Follow-On studies
- Analytical studies
- Accuracy studies
- Dose optimization
- Adaptive clinical trial design
- Power and sample size estimation
- Protocol review
- TLFs
- CSR review
- Regulatory meeting support
- Support for full publication circle
- Full bioinformatics solutions
- Customized methodology development and application
- Survival and longitudinal data analysis
- Real world evidence (RWE) analysis
- Meta-analysis